Vachellia oerfota
Vachellia oerfota · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Vachellia oerfota is a significant medicinal plant frequently utilized in traditional healing practices across various regions. Recent pharmacological investigations have focused on its potential therapeutic efficacy against the Hepatitis B virus. To explore these biological properties, researchers utilized a total ethanol extract derived from the plant's components. This specific preparation aims to concentrate the bioactive compounds necessary for evaluating antiviral activity. Such studies are crucial for determining if this botanical species can serve as a viable source for future antiviral drug development.
- Synonyms
- Mimosa Oerfota · Acacia Oerfota
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Vachellia oerfota is a botanical species that is frequently identified by several different scientific names. In many taxonomic records, it is officially recognized by its synonym, Acacia oerfota. Researchers also commonly refer to this plant using the alternative designation Mimosa oerfota. These varying names highlight the complex history of classification within the plant kingdom. Understanding these relationships is essential for anyone studying the diverse nomenclature of this specific species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Vachellia oerfota is a fascinating specimen that belongs to the diverse kingdom Plantae. Within this vast biological realm, the species is classified under the class Equisetopsida. It further falls into the order Fabales, showcasing its specific evolutionary lineage. The plant is a prominent member of the family Fabaceae, which connects it to many other significant legumes. Ultimately, its botanical identity is defined by its placement within the genus Vachellia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Vachellia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Vachellia oerfota is a resilient species primarily distributed throughout the diverse landscapes of Africa. It is widely established across East Tropical Africa, finding natural habitats within Kenya, Tanzania, and Uganda. Beyond the eastern regions, the plant also extends its reach into Northeast Tropical Africa. Specifically, it can be found growing in the unique environments of both Chad and Djibouti. This broad geographic range highlights the plant's ability to adapt to various African ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Vachellia oerfota is a self-supporting plant that typically takes on a shrub-like growth form. It reaches a modest maximum height of 5 meters in its natural habitat. This compact stature makes it a distinctive feature of its local ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Vachellia oerfota, also referred to in the study as Acacia oerfota, demonstrates novel anti-HBV activities through its total ethanol extract. This plant showed the ability to inhibit the hepatitis B virus in a time- and dose-dependent manner. During the experimental evaluation on HepG2.2.15 cells, the extract achieved a half maximal inhibitory concentration (IC50) value of 101.46. The antiviral efficacy of this species is attributed to the presence of phytochemicals such as alkaloids, tannins, flavonoids, and saponins. Consequently, the plant is recognized as having marked activity against the hepatitis B virus.
Preparations
Vachellia oerfota is prepared as a total ethanol extract to evaluate its potential antiviral properties. This specific extraction method was utilized during the experimental screening of sixty medicinal plants against the hepatitis B virus. The resulting total ethanol extract of the plant demonstrated novel anti-HBV activities in a time- and dose-dependent manner. Testing on HepG2.2.15 cells revealed that this extract achieved an IC50 value of 101.46. Such preparation allows for the analysis of phytochemicals like alkaloids and flavonoids that contribute to its observed efficacy.